Oral ciprofloxacin vs. intramuscular ceftriaxone as <font color="blue">empiric_1</font> <font color="blue">treatment_1</font> <font color="blue">of_1</font> <font color="blue">acute_4</font> <font color="blue">invasive_4</font> <font color="blue">diarrhea_4</font> <font color="blue">in_4</font> <font color="blue">children_4</font> <font color="blue">._4</font> 
<br>
<br> BACKGROUND <font color="blue">Acute_1</font> <font color="blue">invasive_1</font> <font color="blue">diarrhea_1</font> <font color="blue">is_1</font> <font color="blue">a_1</font> <font color="blue">potentially_1</font> <font color="blue">serious_1</font> <font color="blue">condition_1</font> <font color="blue">in_1</font> <font color="blue">children_2</font> <font color="blue">._2</font> Because of the increasing resistance of enteric pathogens to commonly used oral antibiotics , intramuscular ceftriaxone has become the routine drug in the treatment of acute invasive diarrhea requiring an emergency visit in southern <font color="blue">Israel_1</font> <font color="blue">._1</font> The inconvenience of this parenteral regimen created an increased need for oral pediatric formulations for the treatment of invasive diarrhea . 
<br> OBJECTIVES To evaluate the efficacy and safety of a suspension formulation of ciprofloxacin <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">treatment_1</font> <font color="blue">of_1</font> <font color="blue">acute_3</font> <font color="blue">invasive_3</font> <font color="blue">diarrhea_3</font> <font color="blue">in_3</font> <font color="blue">infants_3</font> <font color="blue">and_3</font> <font color="blue">children_3</font> <font color="blue">._3</font> 
<br> PATIENTS AND METHODS <font color="blue">From_2</font> <font color="blue">July_3</font> <font color="blue">1996_3</font> <font color="blue">through_3</font> <font color="blue">December_3</font> <font color="blue">1997_3</font> <font color="blue">,_3</font> <font color="blue">201_5</font> <font color="blue">evaluable_6</font> <font color="blue">children_7</font> <font color="blue">ages_7</font> <font color="blue">6_7</font> <font color="blue">months_7</font> <font color="blue">to_7</font> <font color="blue">10_7</font> <font color="blue">years_7</font> <font color="blue">(_7</font> <font color="blue">35%_7</font> <font color="blue"><_7</font> <font color="blue">1_7</font> <font color="blue">year_7</font> <font color="blue">;_7</font> <font color="blue">70%_7</font> <font color="blue"><3_7</font> <font color="blue">years_7</font> <font color="blue">)_7</font> <font color="blue">presenting_7</font> <font color="blue">with_7</font> <font color="blue">acute_7</font> <font color="blue">invasive_7</font> <font color="blue">diarrhea_7</font> <font color="blue">at_6</font> <font color="blue">the_6</font> <font color="blue">Pediatric_6</font> <font color="blue">Emergency_6</font> <font color="blue">Room_6</font> <font color="blue">were_1</font> <font color="blue">randomized_1</font> <font color="blue">to_1</font> <font color="blue">receive_1</font> <font color="blue">either_1</font> <font color="blue">ciprofloxacin_1</font> <font color="blue">suspension_1</font> <font color="blue">(_1</font> <font color="blue">10_1</font> <font color="blue">mg_1</font> <font color="blue">/_1</font> <font color="blue">kg_1</font> <font color="blue">twice_1</font> <font color="blue">a_1</font> <font color="blue">day_1</font> <font color="blue">+_1</font> <font color="blue">i_1</font> <font color="blue">m_1</font> <font color="blue">placebo_1</font> <font color="blue">;_1</font> <font color="blue">n_1</font> <font color="blue">=_1</font> <font color="blue">95_1</font> <font color="blue">)_1</font> <font color="blue">or_1</font> <font color="blue">i_1</font> <font color="blue">m_1</font> <font color="blue">ceftriaxone_1</font> <font color="blue">(_1</font> <font color="blue">50_1</font> <font color="blue">mg_1</font> <font color="blue">/_1</font> <font color="blue">kg_1</font> <font color="blue">/_1</font> <font color="blue">day_1</font> <font color="blue">+_1</font> <font color="blue">placebo_1</font> <font color="blue">suspension_1</font> <font color="blue">;_1</font> <font color="blue">n_1</font> <font color="blue">=_1</font> <font color="blue">106_1</font> <font color="blue">)_1</font> <font color="blue">for_1</font> <font color="blue">3_1</font> <font color="blue">days_1</font> <font color="blue">in_1</font> <font color="blue">a_1</font> <font color="blue">double_1</font> <font color="blue">blind_1</font> <font color="blue">manner_1</font> <font color="blue">._1</font> Stool cultures for Shigella , Salmonella , Campylobacter spp . and diarrheagenic Escherichia coli were obtained on Days 1 , 3 , 4 to 5 and 21 + /- 5 . Clinical response and safety were assessed on Days 1 , 2 , 3 , 4 to 5 and 21 + /- 5 . 
<br> RESULTS <font color="blue">We_1</font> <font color="blue">isolated_1</font> <font color="blue">127_2</font> <font color="blue">pathogens_2</font> <font color="blue">from_2</font> <font color="blue">121_2</font> <font color="blue">(_2</font> <font color="blue">60%_2</font> <font color="blue">)_2</font> <font color="blue">patients_2</font> <font color="blue">:_2</font> 73 ( 57% ) Shigella ; 23 ( 18% ) Salmonella ; 18 ( 14% ) E. coli ; and 13 ( 10% ) Campylobacter . Overall bacteriologic eradication on Day 4 to 5 was 99% for Shigella , 77% for Salmonella and 77% for Campylobacter , <font color="blue">with_1</font> <font color="blue">no_1</font> <font color="blue">difference_1</font> <font color="blue">between_1</font> <font color="blue">the_1</font> <font color="blue">2_1</font> <font color="blue">groups_1</font> <font color="blue">._1</font> <font color="blue">Clinical_1</font> <font color="blue">cure_1</font> <font color="blue">or_1</font> <font color="blue">improvement_1</font> <font color="blue">was_1</font> <font color="blue">observed_1</font> <font color="blue">in_1</font> <font color="blue">100_1</font> <font color="blue">and_1</font> <font color="blue">99%_1</font> <font color="blue">of_1</font> <font color="blue">the_1</font> <font color="blue">ciprofloxacin_1</font> <font color="blue">and_1</font> <font color="blue">ceftriaxone_1</font> <font color="blue">groups_1</font> <font color="blue">,_1</font> respectively . Serum ciprofloxacin values determined on Day 3 of the treatment <font color="blue">were_1</font> <font color="blue">higher_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">majority_1</font> <font color="blue">of_1</font> <font color="blue">patients_1</font> than were the MIC50 and MIC90 values for the Shigella and Salmonella spp . isolated . Possible <font color="blue">drug_1</font> <font color="blue">-_1</font> <font color="blue">related_1</font> <font color="blue">adverse_1</font> <font color="blue">events_1</font> <font color="blue">occurred_1</font> <font color="blue">in_1</font> <font color="blue">13_1</font> <font color="blue">patients_1</font> [ ciprofloxacin , 8 ( 8% ) ; ceftriaxone , 5 ( 4.7% ) ] and were mild and transient . Joint examination was normal during and after completion of therapy in all patients . 
<br> CONCLUSION Oral ciprofloxacin was as safe and effective as intramuscular ceftriaxone for the empiric treatment of <font color="blue">acute_1</font> <font color="blue">invasive_1</font> <font color="blue">diarrhea_1</font> <font color="blue">in_1</font> <font color="blue">ambulatory_3</font> <font color="blue">pediatric_3</font> <font color="blue">patients_3</font> <font color="blue">requiring_2</font> <font color="blue">an_2</font> <font color="blue">emergency_2</font> <font color="blue">room_2</font> <font color="blue">visit_2</font> <font color="blue">._2</font>